A
Alcista
Alcista · 25%QSI
$4.58
Precio del escenario
$1.120
-0.162 (-14.50%)Al cierre
Loading chart…
- Máximo
- 1.330
- Apertura
- 1.330
- Precio medio ponderado por volumen
- 1.18
- Volumen
- 7.69M
- Capitalización
- 133.31M
- Mínimo
- 1.100
- Importe
- 9.10M
- EV/EBITDA, TTM
- -0.62
Quantum-SI Incorporated is a life sciences company. The Company has designed and developed a hardware, consumable and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins. Its launched product consists of Platinum, the Platinum Analysis Software and consumables. Its flagship protein sequencing instrument, Platinum, is designed to make the power of single-molecule detection and NGPS accessible. Platinum is designed to provide a streamlined workflow compared to legacy MS workflows. Platinum uses its proprietary semiconductor chip that leverages time-domain sequencing with an initial focus on NGPS for an unbiased view of the proteome.
Análisis de IA of Quantum-Si Inc (QSI)
VenderQuantum-Si Inc. is not a good buy right now. The current price is $1.12, and the stock has a 1-year change of -56.67%, indicating severe underperformance. Additionally, the RSI is at 38.07, suggesting it is nearing oversold territory but has not yet shown signs of recovery. The main risk is the high insider selling, which has increased by 336.04% over the last month, indicating a lack of confidence from those closest to the company.
Métricas de valoración
El PER previsto actual de Quantum-Si Inc (QSI) es 0.00, frente a su media de 5 años de -3.22.
Escenarios de precio de Alphio AI para QSI
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.
Cronología de eventos
Noticias
9.508-20NASDAQ.COMQuantum-Si Reports Q2 2026 Financial Results and Proteus Development Update
5.005-14NewsfilterQuantum-Si Grants Restricted Stock Units to New Employees
9.505-08seekingalphaQuantum-Si Q1 2026 Earnings Call Insights
- 1.005-01Newsfilter
Quantum-Si to Participate in H.C. Wainwright BioConnect Investor Conference
- 3.504-28Newsfilter
Quantum-Si Achieves Milestone in Protein Sequencing with Proteus Instruments
Preguntas frecuentes sobre QSI, respondidas por Alphio AI
Quantum-SI Incorporated is a life sciences company. The Company has designed and developed a hardware, consumable and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins. Its launched product consists of Platinum, the Platinum Analysis Software and consumables. Its flagship protein sequencing instrument, Platinum, is designed to make the power of single-molecule detection and NGPS accessible. Platinum is designed to provide a streamlined workflow compared to legacy MS workflows. Platinum uses its proprietary semiconductor chip that leverages time-domain sequencing with an initial focus on NGPS for an unbiased view of the proteome. It operates in the Healthcare sector (MEASURING & CONTROLLING DEVICES, NEC industry).
Quantum-Si Inc. is not a good buy right now. The current price is $1.12, and the stock has a 1-year change of -56.67%, indicating severe underperformance. Additionally, the RSI is at 38.07, suggesting it is nearing oversold territory but has not yet shown signs of recovery. The main risk is the high insider selling, which has increased by 336.04% over the last month, indicating a lack of confidence from those closest to the company.
Comunidad
Más ↗
Wall St is expecting -0.12 EPS for $QSI Q3 [Reporting 11/11 AMC]
Mostrar másEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.